#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA711743	F	In Vitro cytotoxicity on MRC-5 cells	Homo sapiens	3		cell-based format	Scientific Literature
2.	ALA711744	F	Tested for cytotoxicity towards human MRC-5 cells	Homo sapiens	20		cell-based format	Scientific Literature
3.	ALA728741	F	The compound was tested for in vivo activity against a rodent model of Trypanosoma brucei at the specified dose: 5 mg/kg, ip no. of days dosing = 1; All servived	Mus musculus	1		organism-based format	Scientific Literature
4.	ALA814902	F	In vitro antitrypanosomal activity against Trypanosoma brucei rhodesiense	Trypanosoma brucei rhodesiense	65		organism-based format	Scientific Literature
5.	ALA811243	F	50% antitrypanosomal activity against Trypanosoma cruzi	Trypanosoma cruzi	4		organism-based format	Scientific Literature
6.	ALA873886	F	50% antitrypanosomal activity against Trypanosoma rhodesiense	trypanosoma rhodesiense	5		organism-based format	Scientific Literature
7.	ALA814529	F	Evaluated in vitro for antitrypanosomal activity against Trypanosoma brucei	Trypanosoma brucei	18		organism-based format	Scientific Literature
8.	ALA815461	F	In Vitro inhibition concentration against Trypomastigote form of Trypanosoma brucei	Trypanosoma brucei	1		organism-based format	Scientific Literature
9.	ALA817017	F	Minimum concentration producing complete lysis of all trypanosomes within 30 min at 37 degrees C in vitro	Trypanosoma brucei	26		organism-based format	Scientific Literature
10.	ALA852824	F	Ratio of cytotoxicity against L6 cells to that of antitrypanosomal activity against Trypanosoma brucei rhodesiense		37		cell-based format	Scientific Literature
11.	ALA838592	F	In vivo antitrypanosomal activity at a dose of 4*8 mg/kg, i.p., in mice infected with Trypanosoma brucei brucei STIB 795 strain, measured as survival days (control 7 days)	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA838593	F	In vivo antitrypanosomal activity at a dose of 4*8 mg/kg, i.p., in mice infected with Trypanosoma brucei rhodesiense STIB 900 strain, measured as survival days (control 7 days); ND is not determined	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA838705	F	In vivo antitrypanosomal activity at a dose of 4*8 mg/kg, i.p., in mice infected with Trypanosoma brucei brucei STIB 795 strain; Not determined	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA838706	F	In vivo antitrypanosomal activity at a dose of 4*8 mg/kg, i.p., in mice infected with Trypanosoma brucei rhodesiense STIB 900 strain, measured as cured/infected; 4/4	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA831258	B	In vitro inhibitory concentration against P2 aminopurine transporter of Trypanosoma brucei brucei 427 adenosine (0.5 uM) uptake in presence of 1 mM inosine	Trypanosoma brucei brucei	9		single protein format	Scientific Literature
16.	ALA835218	F	Concentration causing cytotoxicity to 50% of L-6 rat skeletal myoblasts	Rattus norvegicus	12		cell-based format	Scientific Literature
17.	ALA826595	F	Inhibitory concentration in vitro against blood stream Trypanosoma brucei rhodesiense incubated for 72 hr at 37 degree C	Trypanosoma brucei rhodesiense	16		organism-based format	Scientific Literature
18.	ALA835870	F	Inhibitory concentration in vitro against intracellular amastigotes of Leishmania donovani in rat skeletal myoblasts incubated for 96 hr at 27 degree C	Leishmania donovani	5		organism-based format	Scientific Literature
19.	ALA835872	F	In vitro inhibitory concentration against intracellular amastigotes of Trypanosoma cruzi in rat skeletal myoblasts incubated for 37 degree C for 4 days	Trypanosoma cruzi	14		organism-based format	Scientific Literature
20.	ALA876323	F	In vivo antitrypanosomal activity at a dose of 4*1 mg/kg, i.p., in mice infected with Trypanosoma brucei brucei STIB 795 strain, measured as survival days (control 7 days)	Mus musculus	1		organism-based format	Scientific Literature